Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans

International Journal of Food Sciences and Nutrition

Volumn 63, Issue 5, 2012, Pages 513-521

  Calani, Luca ^a   Del Rio, Daniele ^a   Luisa Callegari, Maria ^b   Morelli, Lorenzo ^b   Brighenti, Furio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Bioavailability; Colon microbiota; Green tea flavan 3 ols; Mass spectrometry; Polyphenols; Urinary excretion

Indexed keywords

CATECHIN; DRUG DERIVATIVE; FLAVAN 3 OL; FLAVAN-3-OL; FLAVONOID; PLANT MEDICINAL PRODUCT; POLYPHENOL; PROANTHOCYANIDIN;

ADULT; ARTICLE; BIOAVAILABILITY; CHEMISTRY; COLON; HUMAN; INTESTINE; INTESTINE ABSORPTION; METABOLISM; MICROBIOLOGY; PLANT LEAF; TEA; URINE;

ADULT; BIOLOGICAL AVAILABILITY; CAMELLIA SINENSIS; CATECHIN; COLON; FLAVONOIDS; HUMANS; INTESTINAL ABSORPTION; INTESTINES; PLANT LEAVES; PLANT PREPARATIONS; POLYPHENOLS; PROANTHOCYANIDINS; TEA; YOUNG ADULT;

CAMELLIA SINENSIS;

EID: 84863951910     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2011.640311     Document Type: Article

References (32)

1. Appeldoorn MM, Vincken JP, Aura AM, Hollman PC, Gruppen H. 2009. Procyanidin dimers are metabolized by human microbiota with 2-(3,4- dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J Agric Food Chem 57(3):1084-1092.
2. Auger C, Mullen W, Hara Y, Crozier A. 2008. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy. J Nutr 138(8):1535S-1542S.
3. Cabrera C, Artacho R, Giménez R. 2006. Beneficial effects of green tea - a review. J Am Coll Nutr 25(2):79-99. Review. (Pubitemid 46939847)
4. Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, et al. 2005. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11(12):4627-4633. (Pubitemid 40825654)
5. Coughtrie MW, Johnston LE. 2001. Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. Drug Metab Dispos 29(4 Pt 2): 522-528. (Pubitemid 32275528)
6. Crozier A, Del Rio D, Clifford MN. 2010. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31(6): 446-467.
7. Del Rio D, Borges G, Crozier A. 2010a. Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 104(Suppl 3):S67-S90.
8. Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F. 2010b. Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition 26(11-12):1110-1116.
9. Donovan JL, Manach C, Fauks RM, Kroon PA. 2006. Absorption and metabolism of dietary plant secondary metabolites. In: Crozier A, Clifford MN, Ashihara H, editors. Plant secondary metabolites: occurrence, structure and role in the human diet. Oxford: Blackwell Publishing. p 303-351.
10. Düweler KG, Rohdewald P. 2000. Urinary metabolites of French maritime pine bark extract in humans. Pharmazie 55(5):364-368. (Pubitemid 30322228)
11. Henning SM, Niu Y, Liu Y, Lee NH, Hara Y, Thames GD, et al. 2005. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem 16(10):610-616. (Pubitemid 41338373)
12. Kalili KM, de Villiers A. 2010. Off-line comprehensive twodimensional hydrophilic interaction £ reversed phase liquid chromatographic analysis of green tea phenolics. J Sep Sci 33(6-7):853-863.
13. Knights KM, Miners JO. 2010. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Drug Metab Rev 42(1):63-73.
14. Kuriyama S. 2008. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr 138(8):1548S-1553S, Review.
15. Lambert JD, Sang S, Yang CS. 2007. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol Pharm 4(6):819-825.
16. Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, et al. 2002. Pharmacokinetics of tea catechins after ingestion of green tea and (2)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1025-1032. (Pubitemid 35192653)
17. Li C, Lee MJ, Sheng S, Meng X, Prabhu S, Winnik B, et al. 2000. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol 13(3):177-184. (Pubitemid 30169962)
18. Lin LZ, Chen P, Harnly JM. 2008. New phenolic components and chromatographic profiles of green and fermented teas. J Agric Food Chem 56(17):8130-8140.
19. Llorach R, Garrido I, Monagas M, Urpi-Sarda M, Tulipani S, Bartolome B, Andres-Lacueva C. 2010. Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols. J Proteome Res 9(11):5859-5867.
20. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 Suppl):230S-242S.
21. Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MB. 2008. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr 138(8): 1578S-1583S.
22. Mullen W, Edwards CA, Crozier A. 2006. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96(1):107-116. (Pubitemid 44160903)
23. Mullen W, Archeveque MA, Edwards CA, Matsumoto H, Crozier A. 2008. Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J Agric Food Chem 56(23):11157-11164.
24. Roowi S, Stalmach A, MullenW, Lean ME, Edwards CA, Crozier A. 2010. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J Agric Food Chem 58(2): 1296-1304.
25. Sang S, Lee MJ, Yang I, Buckley B, Yang CS. 2008. Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/ electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun Mass Spectrom 22(10):1567-1578. (Pubitemid 351829698)
26. Selma MV, Espín JC, Tomás-Barberán FA. 2009. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57(15):6485-6501.
27. Stalmach A, Troufflard S, Serafini M, Crozier A. 2009. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res 53(Suppl 1):S44-S53.
28. Stalmach A, MullenW, SteilingH,Williamson G, Lean ME, Crozier A. 2010. Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy. Mol Nutr Food Res 54(3):323-334.
29. Stoupi S, Williamson G, Drynan JW, Barron D, Clifford MN. 2010. A comparison of the in vitro biotransformation of (2)-epicatechin and procyanidin B2 by human faecal microbiota. Mol Nutr Food Res 54(6):747-759.
30. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. 2007. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245(1-2):232-241. (Pubitemid 44959362)
31. Tukey RH, Strassburg CP. 2000. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616. (Pubitemid 30340694)
32. Zaveri NT. 2006. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 78(18):2073-2080. Epub 2006 Jan 30. Review.